A case of persistent erythema multiforme treated with upadacitinib

The Journal of DermatologyEarly View LETTER TO THE EDITOR A case of persistent erythema multiforme treated with upadacitinib Jung Min Lee, Jung Min Lee orcid.org/0000-0001-6143-2462 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorYu Jin Lee, Yu Jin Lee orcid.org/0000-0003-0677-4560 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorYun Jeong Choi, Yun Jeong Choi Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorJune Hyunkyung Lee, June Hyunkyung Lee orcid.org/0000-0003-3133-0478 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorJae Eun Choi, Jae Eun Choi orcid.org/0000-0002-1215-7078 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorTae Young Han, Corresponding Author Tae Young Han [email protected] orcid.org/0000-0003-0317-9635 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South Korea Correspondence Tae Young Han, Department of Dermatology, Eulji General Hospital, Eulji University, 68 Hangeulbiseok-ro, Nowon-gu, Seoul 01830, South Korea. Email: [email protected]Search for more papers by this author Jung Min Lee, Jung Min Lee orcid.org/0000-0001-6143-2462 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorYu Jin Lee, Yu Jin Lee orcid.org/0000-0003-0677-4560 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorYun Jeong Choi, Yun Jeong Choi Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorJune Hyunkyung Lee, June Hyunkyung Lee orcid.org/0000-0003-3133-0478 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorJae Eun Choi, Jae Eun Choi orcid.org/0000-0002-1215-7078 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South KoreaSearch for more papers by this authorTae Young Han, Corresponding Author Tae Young Han [email protected] orcid.org/0000-0003-0317-9635 Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, South Korea Correspondence Tae Young Han, Department of Dermatology, Eulji General Hospital, Eulji University, 68 Hangeulbiseok-ro, Nowon-gu, Seoul 01830, South Korea. Email: [email protected]Search for more papers by this author First published: 29 August 2023 https://doi.org/10.1111/1346-8138.16938Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Deutsch A, Rodriguez N, Roy S, Leventhal JS. Treatment of persistent erythema multiforme with upadacitinib: a novel therapeutic approach. JAAD Case Rep. 2023; 34: 70–73. 2Wetter DA, Davis MDP. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol. 2010; 62: 45–53. 3Chen CW, Tsai TF, Chen YF, Hung CM. Persistent erythema multiforme treated with thalidomide. Am J Clin Dermatol. 2008; 9: 123–127. 4Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, et al. Expression of cytokines and chemokine receptors in the cutaneous lesion of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol. 2006; 155: 722–728. 5Murphy MJ, Gruenstein D, Wang A, Peterson D, Levitt J, King B, et al. Treatment of persistent erythema multiforme with janus kinase inhibition and the role of interferon gamma and interleukin 15 and its pathogenesis. JAMA Dermatol. 2021; 157: 1477–1482. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation